Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Nephros (NEPH) Shares Outstanding (Weighted Average) (2016 - 2025)

Historic Shares Outstanding (Weighted Average) for Nephros (NEPH) over the last 17 years, with Q3 2025 value amounting to $10.6 million.

  • Nephros' Shares Outstanding (Weighted Average) rose 64.37% to $10.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $10.6 million, marking a year-over-year increase of 64.37%. This contributed to the annual value of $10.5 million for FY2024, which is 134.01% up from last year.
  • Nephros' Shares Outstanding (Weighted Average) amounted to $10.6 million in Q3 2025, which was up 64.37% from $10.6 million recorded in Q2 2025.
  • Nephros' 5-year Shares Outstanding (Weighted Average) high stood at $10.6 million for Q3 2025, and its period low was $9.9 million during Q1 2021.
  • Moreover, its 5-year median value for Shares Outstanding (Weighted Average) was $10.3 million (2022), whereas its average is $10.3 million.
  • Its Shares Outstanding (Weighted Average) has fluctuated over the past 5 years, first soared by 1504.97% in 2021, then fell by 1.67% in 2023.
  • Over the past 5 years, Nephros' Shares Outstanding (Weighted Average) (Quarter) stood at $10.0 million in 2021, then rose by 2.79% to $10.3 million in 2022, then rose by 0.86% to $10.4 million in 2023, then grew by 1.34% to $10.5 million in 2024, then rose by 0.82% to $10.6 million in 2025.
  • Its last three reported values are $10.6 million in Q3 2025, $10.6 million for Q2 2025, and $10.6 million during Q1 2025.